Malaria commodities in Angola
The National Malaria Control Program’s (NMCP’s) supply chain activities include:
- Improving the availability of malaria commodities at the national and provincial levels
- Data for supply chain decision making
- Strengthened regulatory system for medicines and other pharmaceutical products
- Improved storage conditions for pharmaceutical products.
- Engagement of partners to support the procurement of antimalarial products
- Coordinated national, provincial and municipal procurements
- Funding a portion of the cost for the procurement, and distribution of malaria program commodities
The Angolan Government and donors are responsible for physical warehousing and distribution of commodities used in malaria programming.
Angola’s National Plan for Health 2012–2025 (Plano Nacional de Desenvolvimento Sanitário – PNDS 2012–2025), has highlighted the lack of a comprehensive and strategic supply chain plan as a key challenge to access pharmaceuticals in Angola. As of late 2019, Angola had not finalized a National Supply Chain Strategy, drafted in 2016.
In 2019, the central level of Angola was generally understocked of all but one ACT formulation and injectable artesunate. SP and RDTs were generally stocked according to plan at the central level.
The understocking of ACTs resulted principally from the Angolan Government being unable to meet the NMCP’s commitment to fund 40% of the value of all malaria programme commodity procurements or 70% of all commodities requirements.
At the facility- and community health worker-level, stock-out rates for ACTs, RDTs, and SP were poor in 2019. Because data were only available for a small number of facilities determining the breadth of the problem has, until recently, been a challenge. However, with the central level being understocked for most of 2019, it is likely that stockout rates at other facilities not captured in the analysis were also comparatively high.